antibodies
| 4 min read
Antibody discovery is becoming less about finding the strongest binder and more about finding molecules that can survive the journey to the clinic.
| 4 min read
A new consortium will characterize 10,000 antibodies to a single standard, aiming to train AI models that flag manufacturing risks before candidates advance.
| 5 min read
From computationally designed repertoires to AI-driven specificity prediction and multispecific therapeutics, antibody researchers are developing new ways to design molecules for the biology they need to influence.
| 3 min read
A recombinant antivenom made of five nanobodies protected mice against lethal doses of venom from four medically important snake species in India.
Explore how integrated cell-based assays reveal the mechanisms that drive antibody-drug conjugate activity and inform candidate selection.
| 3 min read
The newly approved drug vastly reduced the amount of antibodies that would usually lead to organ rejection in a patient who had no chance of receiving a matched transplant.
Available on Demand
Explore how charge variant fractionation combined with downstream analysis methods can reveal molecular differences in complex biotherapeutics.
| 3 min read
Researchers showed that an oral medication can activate worn-out T cells.
| 1 min read
The expanded partnership reflects strong demand for Lonza’s global biologics outsourcing platform, spanning diversified clinical and commercial manufacturing programs.
| 4 min read
Biogen’s $850 million move to secure full global rights to felzartamab highlights a deeper shift in how antibody-driven diseases are being understood and treated.
